Joe O’Donoghue Consultant Plastic & Reconstruction Surgeon Newcastle
- 0191 233 6161
- Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne, NE1 4LP
Dr Chris Kalafatis Consultant Psychiatrist Manchester brings unmatched expertise and a strong passion for advancing mental healthcare. Working at the South London & Maudsley NHS Foundation Trust—one of Europe’s most esteemed mental health institutions—he combines academic depth with clinical precision. Additionally, he is an Affiliate at King’s College London, where he leads groundbreaking research in Translational and Cognitive Psychiatry.
Dr Kalafatis leads NHS clinical-academic services that emphasise brain health and digital innovation. He created the first virtual NHS Brain Health Clinic, bringing modern solutions to public healthcare. Moreover, his novel digital cognitive assessment tool uses AI for early detection and population-level analysis. This technology offers both high-resolution individual insights and broad-scale mental health tracking.
From years of NHS and private practice, Dr Chris Kalafatis Consultant Psychiatrist Manchester has identified a recurring issue—undiagnosed ADHD in adults. Many individuals face daily struggles and are often misjudged due to a lack of understanding around neurodiversity. These patients frequently go untreated and face stigma in the workplace. Dr Kalafatis uses a collaborative “two-experts” model, which values both the clinician’s expertise and the patient’s lived experience. This empowers recovery and promotes equality in care.
Early in the 2010s, Dr Kalafatis pioneered telepsychiatry frameworks for outpatient clinics within NHS psychiatric trusts. These virtual assessment tools have since gained both national and international recognition. He has led pharmaceutical trials for Dementia and shared his expertise in digital diagnostics and AI application in psychiatry with global audiences.
Dr Kalafatis has directed memory services for more than 15 years. His work at King’s College London supports large-scale dementia research and pharmaceutical innovation. He has consulted with global pharmaceutical firms on digital biomarkers and brain health, further strengthening his impact on mental health advancements.
To increase accessibility, Dr Kalafatis offers assessments in both English and Greek. This ensures culturally sensitive, patient-centred care across diverse populations.
